Search research articles
Contact Us
Filters
Showing results (131-140 of 167) with videos related to
Page
of 17
Sort By:
International Journal of Cardiology
|
February 10, 2015
Challenges and solutions in medically managed ACS in the Asia-Pacific region: expert recommendations from the Asia-Pacific ACS Medical Management Working Group
, Yong Huo, Peter Thompson, et al.
American Journal of Medical Genetics. Part A
|
May 20, 2004
Unusual features in a patient with neurofibromatosis type 1: multiple subcutaneous lipomas, a juvenile polyp in ascending colon, congenital intrahepatic portosystemic venous shunt, and horseshoe kidney
Cagatay Oktenli, Davut Gul, M Salih Deveci, et al.
American Journal of Medical Genetics
|
February 13, 2002
Study of 250 children with idiopathic mental retardation reveals nine cryptic and diverse subtelomeric chromosome anomalies
Elizabeth Baker, Lyn Hinton, David F Callen, et al.
American Heart Journal
|
September 23, 2024
Exploration of the regional effects of colchicine in the LoDoCo2 trial
Charley A Budgeon, Stefan Nidorf, Arend Mosterd, et al.
Parasites & Vectors
|
March 9, 2021
High prevalence, intensity, and genetic diversity of Trichinella spp. in wolverine (Gulo gulo) from Yukon, Canada
Rajnish Sharma, N Jane Harms, Piia M Kukka, et al.
Circulation
|
March 13, 2002
Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?
R John Simes, Ian C Marschner, David Hunt, et al.
Journal of the American College of Cardiology
|
October 22, 2013
Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease)
Harvey D White, Andrew Tonkin, John Simes, et al.
Journal of the American College of Cardiology
|
May 6, 2014
Reply: the latest generation of troponin immunoassays: the "cholesterol" of the third millennium?
Harvey D White, Andrew Tonkin, John Simes, et al.
Clinical Dysmorphology
|
October 18, 2003
A large deletion (1.5 Mb) encompassing the neurofibromatosis type 1 (NF1) gene in a patient with sporadic NF1 associated with dysmorphism, mental retardation, and unusual ocular and skeletal features
Cagatay Oktenli, Mutlu Saglam, Seref Demirbas, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
March 11, 2003
Skeletal muscle lipid metabolism with obesity
Matthew W Hulver, Jason R Berggren, Ronald N Cortright, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 167) with videos related to
Sort By:
Page
of 17
International Journal of Cardiology
|
February 10, 2015
Challenges and solutions in medically managed ACS in the Asia-Pacific region: expert recommendations from the Asia-Pacific ACS Medical Management Working Group
, Yong Huo, Peter Thompson, et al.
American Journal of Medical Genetics. Part A
|
May 20, 2004
Unusual features in a patient with neurofibromatosis type 1: multiple subcutaneous lipomas, a juvenile polyp in ascending colon, congenital intrahepatic portosystemic venous shunt, and horseshoe kidney
Cagatay Oktenli, Davut Gul, M Salih Deveci, et al.
American Journal of Medical Genetics
|
February 13, 2002
Study of 250 children with idiopathic mental retardation reveals nine cryptic and diverse subtelomeric chromosome anomalies
Elizabeth Baker, Lyn Hinton, David F Callen, et al.
American Heart Journal
|
September 23, 2024
Exploration of the regional effects of colchicine in the LoDoCo2 trial
Charley A Budgeon, Stefan Nidorf, Arend Mosterd, et al.
Parasites & Vectors
|
March 9, 2021
High prevalence, intensity, and genetic diversity of Trichinella spp. in wolverine (Gulo gulo) from Yukon, Canada
Rajnish Sharma, N Jane Harms, Piia M Kukka, et al.
Circulation
|
March 13, 2002
Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?
R John Simes, Ian C Marschner, David Hunt, et al.
Journal of the American College of Cardiology
|
October 22, 2013
Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease)
Harvey D White, Andrew Tonkin, John Simes, et al.
Journal of the American College of Cardiology
|
May 6, 2014
Reply: the latest generation of troponin immunoassays: the "cholesterol" of the third millennium?
Harvey D White, Andrew Tonkin, John Simes, et al.
Clinical Dysmorphology
|
October 18, 2003
A large deletion (1.5 Mb) encompassing the neurofibromatosis type 1 (NF1) gene in a patient with sporadic NF1 associated with dysmorphism, mental retardation, and unusual ocular and skeletal features
Cagatay Oktenli, Mutlu Saglam, Seref Demirbas, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
March 11, 2003
Skeletal muscle lipid metabolism with obesity
Matthew W Hulver, Jason R Berggren, Ronald N Cortright, et al.
Page
of 17